Per 
Item #: SCP-XXXX
Object Class: Safe
Special Containment Procedures: SCP-XXXX is to be kept in Secure Containment Locker 19 at site 24. Usage of SCP-XXXX is strictly limited to D-class for the purpose of testing. All test subjects must be evaluated by a psychologist and receive a Magnetic Resonance Imaging (MRI) scan of their brain before and after testing. Personale under the effects of SCP-XXXX are to have their eyes perminantly covered with a blindfold unless specified otherwise by the project manager. Other means of vision obstruction is currently being researched. Due to the secondary effects of SCP-XXXX, affected personnel must be fed no less than 5 times a day. During each meal, the subject must also intake an amount of potassium and sodium determined by the project manager.
No copies of SCP-XXXX currently exist, however, the foundation has placed multiple advisors in all medical research organizations around the world with a budget exceeding 5 million USD. The primary task of said advisors is to prevent the research and development of physical medication to facial prosopagnosia within reasonable means. Instead, they are to urge for alternate forms of treatment. In the case a physical medication is developed, a sample product must be examined and approved by the foundation before it is allowed to be distributed.
Description: SCP-XXXX is an unbranded 100ml vial containing an unidentified liquid. The container itself has no anomalous properties, however, the contained liquid causes severe alterations to the subject’s ophthalmoception when in contact with their cornea. The amount applied to the subject has no effect on the magnitude of the symptoms nor does applying SCP-XXXX on previously affected subjects cause any change in the symptoms.
SCP-XXXX was recovered from the house of suicide victim Erika Schröder in Berlin, Germany. Background checks of Erika reveals she was working as a medical researcher at the Berlin Institute of Health. Prior to her suicide, she was working on an potential treatment of facial prosopagnosia in the form of eyedrops. Her husband, Hans Schröder, had been diagnosed with severe developmental prosopagnosia at age 5, he was found dead in the bathroom.
All Humans under the effects of SCP-XXXX show increased neural activity in the Primary Visual Cortex (PVC), Optic Chiasm, and the Parahippocampus. The increase in neural activity results in subjects constantly running out of adenosine triphosphate, sodium, and potassium. Subjects also report difficulties falling asleep, electroencephalograms show the affected individuals are completely unable to achieve REM sleep.
Application of SCP-XXXX on humans regardless of facial prosopagnosia results in the subject misinterpreting faces within their field of view to belong to other people they knew prior to the application. Tests and interviews suggest subjects are able to “project” facial features of individuals they previously knew onto faces in their view. The faces subjects see are not replaced if they exit and re-enter the subject’s view. However, this consistency is removed once the subject enters stage 3 nREM sleep. Upon waking up, every face they encounter for the first time since their awakening will be randomly assigned to the face of another individual they previously knew. All pieces of media with the exception of stylized depictions, including but not limited to: Photos, film, and ultra-realistic renderings of faces will also trigger this affect.
Non-prosopagnosic individuals report frequent dreams where they are forced to physically fight against every single person they had met prior to the application of SCP-XXXX. Although the situation is different for every subject, they all share the same traits of an open and vast setting with aggressive versions every person the subject can recollect from their memory. Upon further inspection, this “dream-like” state is triggered whenever the subject enters stage 4 nREM sleep. During this process, the subject express abnormally high activity in the occipital and temporal lobes, putting the subject into a state of minimal wakefulness with high awareness.
Test XXXX-3: (Use of SCP-XXXX on Prosopagnosia victim)
Test XXXX-6: (Use of SCP-XXXX on “normal” D-class)
Interview with D-XXXX:
Test XXXX-9: (Use of SCP-XXXX on animals)
Addendum 1: As of June 6th, 2004, testing of SCP-XXXX should occur no more than once per week. Testing subjects may not include any organisms other than D-class. Due to the nature of SCP-XXXX, the potential loss of valuable assets has been determined too dangerous by the site director.
(Amestetics)
Test XXXX-11: (Affect subject was asked to look into a mirror) Isoelectric EEG, braindeath of test subject
Addendum 2: Following Test XXXX-11, the testing center and evaluation room for SCP-XXXX must be devoid of all reflective surfaces.
